Adding EGFR staining increased the sensitivity of identifying ER- cancers with loss of wt BRCA1 (28/28; 100%), however it lowered the specificity as three of four of the ER- cancers without loss of wt BRCA1 (75%) stained for EGFR. The gene discussed is EGFR; the disease is cancer.